Only two commercial ranitidine products were assessed for NDMA content via analysis. Powdered samples (100 to 500 mg) were introduced to 10 mL headspace vials for headspace analysis without ...
This lawsuit concerns GSK’s fraud on the federal and state governments and the money spent on ranitidine products by governments because of that fraud. Whether ranitidine increases the risk of cancer ...
The previous year, UK doctors were told to stop prescribing four types of Zantac as a "precautionary measure". It followed concerns in several countries that the products may contain the impurity.
The company and other pharma groups that have sold ranitidine products over the years have so far been fairly successful in fending off the litigation, with wins in the US and Canada, but there ...
GSK and other pharma companies that have sold ranitidine products over the years have so far been fairly successful in fending off the litigation, with wins in the US and Canada, and the Delaware ...
GlaxoSmithKline ( (GSK) ) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
Some top local politicians cut the ribbon Monday for a New Haven lab that works to test everyday products to make sure they ...
This came after studies revealed that ranitidine products might have unhealthy levels of NDMA, a known probable carcinogen that can lead to the development of cancer in users. While former Zantac ...
These products broadly target infectious diseases ... GSK also seems to have solved 93% of Zantac's lawsuits without admitting liability. Its pipeline seems significantly diversified across ...
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
“Ranitidine, used for acid reflux, was recalled a few years back for similar concerns.” Nitrosamines are chemicals found in various foods, drinking water, cosmetics, and tobacco ...
On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against ...